longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

CHINA REFORM HEALTH

000503

6.850.44% ( +0.03 )
Delay Closed: Sep 14, 15:00:00
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -16.47, above the reasonable range, cheaper than 3.58% of the time in the past 3 years, and the industry ranks 8/9, the industry Median 35.86.

-16.47xP/E
¥6.85Stock price
¥-0.42Earnings per share
-16.47xP/E
Stock price¥6.85Earnings per share¥-0.42

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-123.63x
Typical range
-677.52x–-76.27x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 35.86x
0326496128

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 35.86x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
600682SHNJXB
-7.98x--¥7.76B
000503SZCHINA REFORM HEALTH
-16.47x102.42%¥6.71B
002622SZWHOLE SHINE MEDICAL
-19.83x--¥2.18B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.